| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 7.49B | — |
| Operating expense | — | — |
| Net income | 1.97B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GNMSF returned +37.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +7.3% |
| 1 year | +37.9% |
| 5 years | -29.4% |
| 10 years | +108.0% |
| All-time high | $477.57 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in GNMSF would be worth today ›No. Genmab A/S has not paid a dividend in the past 12 months.
Genmab A/S is part of the Healthcare sector.
Genmab A/S has a market cap of 20.71B USD, based on the latest quote.
Genmab A/S is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
